Cart
sales@molnova.com
3'-Methoxyflavonol
CAS No. 76666-32-5
3'-Methoxyflavonol( —— )
Catalog No. M21419 CAS No. 76666-32-5
3'-Methoxyflavonol is a selective agonist of neuromedin U 2 receptor (NMU2R).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 43 | In Stock |
|
| 25MG | 29 | In Stock |
|
| 50MG | 38 | In Stock |
|
| 100MG | 52 | In Stock |
|
| 200MG | 74 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name3'-Methoxyflavonol
-
NoteResearch use only, not for human use.
-
Brief Description3'-Methoxyflavonol is a selective agonist of neuromedin U 2 receptor (NMU2R).
-
Description3'-Methoxyflavonol is a selective agonist of neuromedin U 2 receptor (NMU2R).
-
In Vitro3'-Methoxyflavonol (NRA 10) is a selective agonist of neuromedin U 2 receptor (NMU2R).
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorNMU2R
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number76666-32-5
-
Formula Weight268.26
-
Molecular FormulaC16H12O4
-
Purity>98% (HPLC)
-
SolubilityDMSO:155 mg/mL (577.8 mM and warming)
-
SMILESCOC1=CC=CC(=C1)C2=C(C(=O)C3=CC=CC=C3O2)O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Ma ML et al. Design synthesis and biological activity of flavonoid derivatives as selective agonists for neuromedin U 2 receptor. Bioorg Med Chem. 2014 Nov 1;22(21):6117-23.
molnova catalog
related products
-
ent-Ezetimibe
Ezetimibe is a Niemann-Pick C1-like1 (NPC1L1) inhibitor, and is a potent Nrf2 activator.ent-Ezetimibe (ent-SCH 58235) is the RRS-enantiomer of Ezetimibe. Ezetimibe is a potent cholesterol absorption inhibitor.?
-
4-Demethyldehydropod...
4'-Demethyldehydropodophyllotoxin is an aryltetralin lignan that can be isolated from leaves of Podophyllum hexandrum. 4'-Demethyldehydropodophyllotoxin exhibits some cytotoxic and antitumour activity.
-
Acetylshikonin
Acetylshikonin can effectively inhibit tumor cells, it can be used to treat hepatocellular carcinoma cells expressing hepatitis B virus X protein (HBX) by inducing ER stress .
